Published June 25, 2024 | Version v1
Patent Open

Compositions comprising Sel1-derived peptides and methods of treatment/prevention of excess oxalate levels and associated conditions/diseases therewith

  • 1. University of Chicago

Contributors

Patent applicant:

Description

Provided herein are compositions comprising Sel1-derived peptides thereof, and method of use thereof for the treatment/prevention excess oxalate levels and conditions and diseases related thereto. In particular, peptides comprise Sel-like repeat (SLR) domains and/or tetratricopeptide (TPR) domains and may be linked together or with other peptides or polypeptides to treat/prevent diseases/conditions related to excess oxalate levels, such as hyperoxaluria and/or hyperoxalemia.

Files

US_12016899_B2.pdf

Files (1.9 MB)

Name Size Download all
md5:547936a1d2d643160934abec936ba4c8
1.9 MB Preview Download

Additional details

Identifiers

Patent number
US 12016899 B2
Patent application number
201917260690
Other
oai:uchicago.tind.io:12991

Dates

Patent filed
2019-07-18

UChicago Information

Division(s)
Biological Sciences Division
Department(s)
Medicine, Microbiology